ProCE Banner Activity

Integrating A New Therapy Into the Clinical Management of Anemia in MDS

Clinical Thought
How will you incorporate luspatercept into your clinical practice for your patients with anemia associated with MDS? Learn from an expert in this commentary.

Released: October 14, 2020

Expiration: October 13, 2021

Share

Faculty

Guillermo Garcia-Manero

Guillermo Garcia-Manero, MD

Professor, Division of Cancer Medicine
Chief, Section of Myelodysplastic Syndromes
Division of Cancer Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb

Faculty Disclosure

Primary Author

Guillermo Garcia-Manero, MD

Professor, Division of Cancer Medicine
Chief, Section of Myelodysplastic Syndromes
Division of Cancer Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Guillermo Garcia-Manero, MD, has disclosed that he has received consulting fees from Bristol-Myers Squibb and Taiho and funds for research support from Bristol-Myers Squibb.